Healthy Extracts Inc.

HYEX

US42227D2099

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 01:31:41 2024-04-10 pm EDT			5-day change	1st Jan Change
2 ^USD	-10.31%		0.00%	-72.22%

Apr. 18	Healthy Extracts Inc. cancelled the acquisition of Hyperion, L.L.C. and Online Publishing & Marketing, LLC.	CI
Apr. 01	Healthy Extracts Inc. Provides Revenue Guidance for the First Quarter of 2024	CI

Healthy Extracts Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023

November 14, 2023 at 05:59 pm EST

Healthy Extracts Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 0.613541 million compared to USD 0.499653 million a year ago. Revenue was USD 0.613541 million compared to USD 0.499653 million a year ago. Net loss was USD 0.247924 million compared to USD 0.170223 million a year ago.
For the nine months, sales was USD 1.82 million compared to USD 1.43 million a year ago. Revenue was USD 1.82 million compared to USD 1.43 million a year ago. Net loss was USD 2.09 million compared to USD 1.03 million a year ago. Basic loss per share from continuing operations was USD 1.2.

Latest news about Healthy Extracts Inc.

Healthy Extracts Inc. cancelled the acquisition of Hyperion, L.L.C. and Online Publishing & Marketing, LLC.	Apr. 17	CI
Healthy Extracts Inc. Provides Revenue Guidance for the First Quarter of 2024	Apr. 01	CI
Healthy Extracts Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
Healthy Extracts Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year Ended December 31, 2023; Provides Revenue Guidance for the First Quarter of 2024	Mar. 13	CI
Healthy Extracts Launches First Anti-Aging Formulation, LONGEVITY	Jan. 04	CI
Healthy Extracts Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Healthy Extracts Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Healthy Extracts Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Healthy Extracts Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31	CI
Healthy Extracts Inc. Auditor Raises 'Going Concern' Doubt	23-03-30	CI
Healthy Extracts Inc. announced that it expects to receive $0.3 million in funding	23-03-19	CI
Healthy Extracts Inc. has filed an IPO in the amount of $9.2 million.	23-02-09	CI
Healthy Extracts Inc. announced that it expects to receive $0.388888 million in funding	23-01-23	CI
Healthy Extracts Inc. entered into an acquisition agreement to acquire Hyperion, L.L.C. and Online Publishing & Marketing, LLC for $4.3 million..	23-01-19	CI
Healthy Extracts Inc’s Whitney Johns Launches Brain Activate ENERGY Gel Packs on WhitneyJohns.com	22-12-06	CI
Earnings Flash (HYEX) HEALTHY EXTRACTS Reports Q3 Revenue $499.7M	22-11-09	MT
Earnings Flash (HYEX) HEALTHY EXTRACTS Posts Q3 EPS $0.00	22-11-09	MT
Earnings Flash (HYEX) HEALTHY EXTRACTS Reports Q3 Revenue $499.7M	22-11-09	MT
Healthy Extracts Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-08	CI
Healthy Extracts Launches Whitney Johns Citrus Bergamot for Women’S Heart Health and Overall Health Exclusively on Amazon	22-09-20	CI
Healthy Extracts Inc. Provides Revenue Guidance for the Year 2022	22-08-15	CI
Healthy Extracts Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI
Healthy Extracts Inc. Launches Citrus Bergamot SuperFruit Heart Health Supplement, Bergamet Pro+	22-08-03	CI
Healthy Extracts Inc. Launches New Clinical Study Investigating UBN ACTIVATE Effect on Golfers Energy, Focus and Scores	22-07-26	CI
Healthy Extracts Inc. Provides Revenue Guidance for the Second Quarter and First Half Ended June 30, 2022	22-07-13	CI

Chart Healthy Extracts Inc.

Duration

Period

More charts

Company Profile

Healthy Extracts, Inc. is a platform for acquiring, developing, researching, patenting, marketing, and distributing plant-based nutraceuticals. The Company operates through its two subsidiaries, BergaMet NA, LLC (Bergamet) and Ultimate Brain Nutrients, LLC (UBN). The Company develops, manufactures and distributes bergamot-based products (BPF) in tablet and capsule under BergaMet Pro+, BergaMet Mega+O, BergaMet HERHEART, BergaMet Cholesterol Command, BergaMet SPORTSHEART and BergaMet CLINICAL IMMUNE. BPF Bergamet products are distributed in North America that contain Citrus Bergamot SuperFruit. Its BergaMet products are certified organic, vegan friendly, non-GMO and gluten-free. Its UBN develops plant-based health technology neuro-products to improve brain health, including memory, cognition, focus and neuro-energy. Its brain health products are sold under various product labels, including UBN ACTIVATE, UBN RELIEF, Brain Activate-Gel and Brain Activate - ENERGY Gel.

Sector

Pharmaceuticals

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
HEALTHY EXTRACTS INC.	-72.22%	5.93M
DONG-E-E-JIAO CO.,LTD.	+35.04%	5.92B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.13%	4.51B
TASLY PHARMACEUTICAL GROUP CO., LTD	-9.75%	3.15B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+2.14%	3.1B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-6.82%	2.42B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+47.87%	1.97B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-7.89%	1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.09%	1.65B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-12.97%	1.53B